Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6988277 | 0.98 | ALDH1A1 (0.57) | SRD5A2ALDH1A1KDM4EPOLBRXFP1 | |
| SCHEMBL5187550 | 0.95 | ALDH1A1 (0.57) | SRD5A2ALDH1A1KDM4EPOLBRXFP1 | |
| SCHEMBL5187629 | 0.91 | SLC18A3 (0.56) | SRD5A2ALDH1A1KDM4EPOLBRXFP1 | |
| SCHEMBL13874024 | 0.83 | MEN1 (0.66) | ALDH1A1KDM4EPOLBRXFP1SLC18A3 | |
| Hydrochloric Acid SCHEMBL3846012 | 0.81 | MEN1 (0.69) | ALDH1A1KDM4EPOLBRXFP1SLC18A3 | |
| SCHEMBL507614 | 0.79 | KMT2A (0.66) | SRD5A2ALDH1A1POLBKMT2AMEN1 | |
| SCHEMBL4771785 | 0.79 | SLC18A3 (0.56) | ALDH1A1KDM4EPOLBRXFP1SLC18A3 | |
| SCHEMBL21077978 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EPOLBRXFP1SLC18A3 | |
| SCHEMBL1554062 | 0.78 | SRD5A2 (0.49) | SRD5A2ALDH1A1KDM4EPOLBRXFP1 | |
| SCHEMBL7486159 | 0.77 | SRD5A2 (0.65) | SRD5A2ALDH1A1POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585431-B1 | METAL FREE BLEACHING COMPOSITION | BASF SE (DE) | 2017-09-06 | — | — | EP | disclosed |
| EP-2585431-B1 | METAL FREE BLEACHING COMPOSITION | BASF SE (DE) | 2017-09-06 | — | — | EP | disclosed |
| US-9657435-B2 | Metal free bleaching composition | BASF SE (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9657435-B2 | Metal free bleaching composition | BASF SE (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9657435-B2 | Metal free bleaching composition | BASF SE (DE) | 2017-05-23 | — | — | US | disclosed |
| CN-102958909-B | metal-free bleaching compositions | 巴斯夫欧洲公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20130117941-A1 | METAL FREE BLEACHING COMPOSITION | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-20130117941-A1 | METAL FREE BLEACHING COMPOSITION | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-20130117941-A1 | METAL FREE BLEACHING COMPOSITION | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-7776884-B2 | Cyclic derivatives as modulators of chemokine receptors activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-08-17 | — | — | US | disclosed |
| US-7087604-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-08-08 | — | — | US | disclosed |
| US-20060135503-A1 | Cyclic derivatives as modulators of chemokine receptors activity | CHERNEY ROBERT J | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135503-A1 | Cyclic derivatives as modulators of chemokine receptors activity | CCL11, CCR1, CCL2 | SRD5A2 492/4885ALDH1A1 1022/4885KDM4E 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.